These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 2982511)

  • 1. Tumour cell resistance to anthracyclines--a review.
    Kaye S; Merry S
    Cancer Chemother Pharmacol; 1985; 14(2):96-103. PubMed ID: 2982511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
    Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circumvention of resistance to anthracyclines by calcium antagonists and other membrane-perturbing agents.
    Kessel D
    Cancer Surv; 1986; 5(1):109-27. PubMed ID: 3297311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.
    Klohs WD; Steinkampf RW; Havlick MJ; Jackson RC
    Cancer Res; 1986 Sep; 46(9):4352-6. PubMed ID: 3460695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics.
    Tsuruo T
    Cancer Treat Rep; 1983 Oct; 67(10):889-94. PubMed ID: 6354436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markedly reduced levels of anthracycline-induced DNA strand breaks in resistant P388 leukemia cells and isolated nuclei.
    Capranico G; Riva A; Tinelli S; Dasdia T; Zunino F
    Cancer Res; 1987 Jul; 47(14):3752-6. PubMed ID: 3474061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased toxicity of anthracycline antibiotics induced by calcium entry blockers in cultured cardiomyocytes.
    Santostasi G; Kutty RK; Krishna G
    Toxicol Appl Pharmacol; 1991 Mar; 108(1):140-9. PubMed ID: 2006501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions among membrane transport systems: anthracyclines, calcium antagonists and anti-estrogens.
    Kessel D
    Biochem Pharmacol; 1986 Aug; 35(16):2825-6. PubMed ID: 2943288
    [No Abstract]   [Full Text] [Related]  

  • 10. Anthracycline subcellular distribution in human leukemic cells by microspectrofluorometry: factors contributing to drug-induced cell death and reversal of multidrug resistance.
    Morjani H; Millot JM; Belhoussine R; Sebille S; Manfait M
    Leukemia; 1997 Jul; 11(7):1170-9. PubMed ID: 9205008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane transport of anthracyclines.
    Skovsgaard T; Nissen NI
    Pharmacol Ther; 1982; 18(3):293-311. PubMed ID: 6762567
    [No Abstract]   [Full Text] [Related]  

  • 12. Interactions between calcium antagonists, calcium fluxes and anthracycline transport.
    Kessel D; Wilberding C
    Cancer Lett; 1984 Nov; 25(1):97-101. PubMed ID: 6097354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemosensitizers counteracting acquired resistance to anthracyclines and vinca alkaloids in vivo. A new treatment principle.
    Skovsgaard T; Danø K; Nissen NI
    Cancer Treat Rev; 1984 Mar; 11 Suppl A():63-72. PubMed ID: 6375864
    [No Abstract]   [Full Text] [Related]  

  • 14. Anthracycline antibiotics in cancer therapy. Focus on drug resistance.
    Booser DJ; Hortobagyi GN
    Drugs; 1994 Feb; 47(2):223-58. PubMed ID: 7512899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of resistance to anthracyclines and vinca alkaloids.
    Danø K; Skovsgaard T; Nissen NI; Friche E; Di Marco A
    Prog Clin Biol Res; 1983; 132C():231-46. PubMed ID: 6579564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthracycline resistance.
    Friche E; Skovsgaard T; Nissen NI
    Acta Oncol; 1989; 28(6):877-81. PubMed ID: 2692650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
    Kessel D; Wilberding C
    Cancer Res; 1985 Apr; 45(4):1687-91. PubMed ID: 3919944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modes of resistance to anthracyclines and other natural products.
    Kessel D; Romine M; Decker D
    Prog Clin Biol Res; 1986; 223():81-93. PubMed ID: 3543948
    [No Abstract]   [Full Text] [Related]  

  • 19. Anthracyclines.
    Sinha BK; Politi PM
    Cancer Chemother Biol Response Modif; 1990; 11():45-57. PubMed ID: 2223402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of doxorubicin cytotoxicity by the calcium antagonist bepridil in anthracycline-resistant and -sensitive cell lines. A comparison with verapamil.
    Schuurhuis GJ; Broxterman HJ; van der Hoeven JJ; Pinedo HM; Lankelma J
    Cancer Chemother Pharmacol; 1987; 20(4):285-90. PubMed ID: 3500807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.